Introduction: Psychedelic-assisted therapy has resurfaced as a promising intervention for treatment-resistant psychiatric disorders. However, regulatory pathways differ considerably across countries because of social, ethical, legal, and political factors. Methods: This review was conducted using the regulatory frameworks of Australia, Brazil, and the USA, along with publicly accessible data,...
Designer drugs are synthetic analogs of controlled substances engineered to replicate pharmacological effects while circumventing legal restrictions.Their emergence can be traced to the 1960s, with the synthesis of novel psychoactive compounds by chemists like Alexander Shulgin, followed by the proliferation of 3,4-methylenedioxymethamphetamine (MDMA) in the 1980s and synthetic cannabinoids and...